Jeffrey Hung – Morgan Stanley

Morgan Stanley

A Morgan Stanley analyst with 52 tracked ratings covering 19 distinct tickers has issued 29 bullish and 8 bearish ratings, with all ratings sourced from a single category as of May 14, 2026.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

21 days ago

2026-05-14 00:00:00+00

Track record

Aggregated

54% success rate

Bullish: 0
Hold: 1
Bearish: 0

Aggregated

Not available

Bullish: 29
Hold: 0
Bearish: 8

Recent ratings

Ticker	Date	Rating	Price target	Source
CTNM	2026-05-14	unknown	$16.00	Aggregated
CYTK	2026-05-06	buy	$103.00	Aggregated
NBIX	2026-05-06	unknown	$191.00	Aggregated
RARE	2026-04-16	buy	$67.00	Aggregated
NBIX	2026-04-10	unknown	$185.00	Aggregated
BCYC	2026-04-08	unknown	$12.00	Aggregated
RYTM

Tickers covered(49)

Ticker	Ratings	Last rating	Sources
CTNM	6	2026-05-14	Aggregated
CYTK	2	2026-05-06	Aggregated
NBIX	3	2026-05-06	Aggregated
RARE	1	2026-04-16	Aggregated
BCYC	3	2026-04-08	Aggregated
RYTM	1	2026-03-17	Aggregated
JAZZ	5	2026-02-25	Aggregated
PTCT	2	2026-02-23	Aggregated
BIOA	3	2025-12-08	Aggregated
ENGN	4	2025-11-12	Aggregated
ENGNENGENE HOLDINGS INC	1	2025-11-12	Aggregated
NBIXNEUROCRINE BIOSCIENCES, INC.	1	2025-11-11	Aggregated
JAZZJAZZ PHARMACEUTICALS PLC	1	2025-10-20	Aggregated
RYTMRHYTHM PHARMACEUTICALS INC.	1	2025-10-16	Aggregated
CGON	3	2025-09-17	Aggregated
CGONCG ONCOLOGY INC.	1	2025-09-17	Aggregated
PTCTPTC THERAPEUTICS INC	1	2025-08-20	Aggregated
CGEM	2	2025-08-18	Aggregated
CGEMCULLINAN THERAPEUTICS INC	1	2025-08-18	Aggregated
CTNMCONTINEUM THERAPEUTICS INC. - ORDINARY SHARES - CLASS A	1	2025-08-18	Aggregated
ERAS	2	2025-08-18	Aggregated
ERASERASCA INC	1	2025-08-18	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	1	2025-08-12	Aggregated
RAREULTRAGENYX PHARMACEUTICAL INC.	1	2025-07-14	Aggregated
ACADACADIA PHARMACEUTICALS INC	1	2025-05-20	Aggregated
CNTA	2	2025-03-07	Aggregated
IRON	1	2025-03-07	Aggregated
CYTKCYTOKINETICS INC	1	2025-02-13	Aggregated
FOLDAMICUS THERAPEUTICS INC	1	2024-12-13	Aggregated
BIOABIOAGE LABS, INC. COMMON STOCK	1	2024-10-21	Aggregated
CNTACENTESSA PHARMACEUTICALS PLC - ADR	1	2024-09-19	Aggregated
IRONDISC MEDICINE INC	1	2024-04-02	Aggregated
CRNXCRINETICS PHARMACEUTICALS INC	1	2024-01-16	Aggregated
IVVDINVIVYD INC	1	2023-12-19	Aggregated
PRLD	4	2023-12-19	Aggregated
PRLDPRELUDE THERAPEUTICS INC	1	2023-12-19	Aggregated
VIGLVIGIL NEUROSCIENCE INC	1	2023-12-19	Aggregated
ADCTADC THERAPEUTICS SA	1	2023-07-11	Aggregated
ITCIINTRA-CELLULAR THERAPIES INC	1	2023-07-11	Aggregated
IMRXIMMUNEERING CORP - ORDINARY SHARES CLASS A	1	2023-04-19	Aggregated
ESPRESPERION THERAPEUTICS INC.	1	2023-03-20	Aggregated
RPTXREPARE THERAPEUTICS INC	1	2023-02-03	Aggregated
CELU	2	2023-01-30	Aggregated
EXELEXELIXIS INC	1	2022-11-02	Aggregated
EVFM	5	2022-07-15	Aggregated
BHVN	2	2022-05-11	Aggregated
BHVNBIOHAVEN LTD	1	2022-05-11	Aggregated
CELUCELULARITY INC - ORDINARY SHARES - CLASS A	1	2021-11-24	Aggregated
APRE	3	2021-08-13	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.